MedCanHub: a platform developed by Cellen aimed at reducing barriers of access to unlicensed cannabis-based medicinal products during the COVID-19 pandemic.

Unlicensed cannabis-based medicinal products (UCBPMs) were reclassified from Schedule 1 to Schedule 2 in 2018 in the UK, allowing doctors on the Specialist Register of the General Medical Council to legally issue prescriptions for UCBPMs.[1,2][1] However, there has been evidence showing that